共 50 条
Risk factors associated with prognosis of patients with medication-related osteonecrosis of the jaw
被引:0
|作者:
Tadokoro, Yoshiaki
[1
]
Hasegawa, Takumi
[1
,2
]
Takeda, Daisuke
[1
]
Murakami, Aki
[1
]
Yatagai, Nanae
[1
]
Arimoro, Satomi
[1
]
Iwata, Eiji
[1
]
Saito, Izumi
[1
]
Kusumoto, Junya
[1
]
Akashi, Masaya
[1
]
机构:
[1] Kobe Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kobe, Japan
[2] Kobe Univ, Grad Sch Med, Dept Oraland Maxillofacial Surg, Kobe 6500017, Japan
来源:
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
|
2024年
/
46卷
/
02期
关键词:
medication-related osteonecrosis of the jaw;
osteolysis;
prognosis;
risk factors;
sequestration;
BISPHOSPHONATE-RELATED OSTEONECROSIS;
MULTIPLE-MYELOMA;
CANCER-PATIENTS;
POSITION PAPER;
MANAGEMENT;
DENOSUMAB;
D O I:
10.1002/hed.27574
中图分类号:
R76 [耳鼻咽喉科学];
学科分类号:
100213 ;
摘要:
Objectives: Medication-related osteonecrosis of the jaw (MRONJ) is a severe adverse effect of antiresorptive and/or antiangiogenic agents. As the treatment application for MRONJ is controversial, we aimed to identify the risk factors for poor prognosis and to help determine appropriate management.Methods: This study included 119 patients. Relevant clinical data were obtained for all the patients. In computed tomography images, osteosclerosis, osteolysis, cortical perforation (buccal or lingual), periosteal reaction, and sequestration were evaluated.Results: Multivariate analyses showed statistically significant associations between poor prognosis in patients with MRONJ and conservative treatment alone (hazard ratio [HR] 1.89), osteolysis (HR 4.67), and the absence of sequestration (HR 5.33).Conclusions: Conservative treatment alone without clear objectives needs to be avoided, and osteolytic change could be the criteria for surgical intervention. As the boundary between the lesion and vital bone is indistinct, we recommend extensive surgery in cases with unpredictable sequestration.
引用
收藏
页码:282 / 290
页数:9
相关论文